Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
Science Advances|September 13, 2021
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaquesKevin R Bewley, Karen Gooch, Kelly M Thomas, et al.
Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The Lancet. Infectious Diseases|October 16, 2020
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort studyRuth Thom, Thomas Tipton, Thomas Strecker, et al.
Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Pageof 5